Protective effect of pretreatment with cilostazol on cytotoxicity of cadmium and arsenite in cultured vascular endothelial cells

Journal of Toxicological Sciences

Volumn 36, Issue 2, 2011, Pages 155-161

  Fujiwara, Yasuyuki ^a   Banno, Hiroki ^a   Shinkai, Yasuhiro ^b   Yamamoto, Chika ^c   Kaji, Toshiyuki ^d   Satoh, Masahiko ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c HOKURIKU UNIVERSITY   (Japan)

^d TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Arsenite; Atherosclerosis; Cadmium; Cilostazol; Metallothionein; Vascular endothelial cell

Indexed keywords

ARSENIC TRIOXIDE; CADMIUM; CILOSTAZOL; LACTATE DEHYDROGENASE; MESSENGER RNA; METALLOTHIONEIN; METALLOTHIONEIN I;

ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CELL DAMAGE; CELL PROTECTION; CYTOTOXICITY; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; MORPHOLOGY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR DISEASE; WESTERN BLOTTING;

EID: 79955376418     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.36.155     Document Type: Article

References (36)

1. Cai, L., Satoh, M., Tohyama, C. and Cherian, M.G. (1999): Metallothionein in radiation exposure its induction and protective role. Toxicology, 132, 85-98.
2. Coyle, P., Philcox, J.C., Carey, L.C. and Rofe, A.M. (2002): Metallothionein: the multipurpose protein. Cell. Mol. Life Sci., 59, 627-647.
3. Dunn, M.A. and Cousins, R.J. (1989): Kinetics of zinc metabolism in the rat: effect dibutyryl cAMP. Am. J. Physiol., 256, E420-E430.
4. Engle, R.R., Hopenhayn-Rich, C., Receveur, O. and Smith, A.H. (1994): Vascular effects of chronic arsenic exposure: a review. Epidemiol. Rev., 16, 184-209.
5. Fujiwara, Y., Kitagawa, T., Shinkai, Y., Kaji, T. and Satoh, M. (2009): Cilostazol induces metallothionein expression in vascular cells. Yakugaku Zasshi, 129, 1415-1422.
6. Fujiwara, Y., Honda, A. and Satoh, M. (2010): DNA microarray gene expression analysis of human vascular endothelial cells exposed to arsenite. J. Toxicol. Sci., 35, 275-278.
7. Fujiwara, Y., Honda, A., Yamamoto, C., Kaji, T. and Satoh, M. (2011): DNA microarray analysis of human coronary artery endothelial cells exposed to cadmium. J. Toxicol. Sci., 36, 141-143.
8. Goering, P.L. and Klaassen, C.D. (1984): Zinc-induced tolerance to cadmium hepatotoxicity. Toxicol. Appl. Pharmacol., 74, 299-307.
9. Hashimoto, A., Miyakoda, G., Hirose, Y. and Mori, T. (2006): Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A-and phosphatidylinositol 3-kinase/Aktdependent mechanism. Atherosclerosis, 189, 350-357.
10. Houtman, J.P. (1993): Prolonged low-level cadmium intake and atherosclerosis. Sci. Total Environ., 138, 31-36.
11. Kaji, T. (2004): Cell biology of heavy metal toxicity in vascular tissue. Yakugaku Zasshi, 124, 113-120.
12. Kaji, T., Mishima, A., Yamamoto, C., Sakamoto, M. and Koizumi, F. (1992): Effect of cadmium on the monolayer maintenance of vascular endothelial cells in culture. Toxicology, 71, 267-276.
13. Kim, K.Y., Shin, H.K., Choi, J.M. and Hong, K.W. (2002): Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. J. Pharmacol. Exp. Ther., 300, 709-715.
14. Kimura, Y., Tani, T., Kanbe, T. and Watanabe, K. (1985): Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzenimittelforschung, 35, 1144-1149.
15. Laemmli, U.K. (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
16. Leber, A.P. and Miya, T.S. (1976): A mechanism for cadmium-and zinc-induced tolerance to cadmium toxicity: involvement of metallothionein. Toxicol. Appl. Pharmacol., 37, 403-414.
17. Miles, A.T., Hawksworth, G.M., Beattie, J.H. and Rodilla, V. (2000): Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol., 35, 35-70.
18. Mishima, A., Kaji, T., Yamamoto, C., Sakamoto, M. and Kozuka, H. (1995): Zinc-induced tolerance to cadmium cytotoxicity without metallothionein induction in cultured bovine aortic endothelial cells. Toxicol. Lett., 75, 85-92.
19. Morishita, R., Higaki, J., Hayashi, S.I., Yo, Y., Aoki, M., Nakamura, S., Moriguchi, A., Matusushita, H., Matsumoto, K., Nakamura, T. and Ogihara, T. (1997): Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor. Diabetologia, 40, 1053-1061.
20. Munro, J.M. and Cotran, R.S. (1988): The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest., 58, 249-261.
21. Nolan, C.V. and Shaikh, Z.A. (1986): The vascular endothelium as a target tissue in acute cadmium toxicity. Life Sci., 39, 1403-1409.
22. Nonaka, Y., Tsuruma, K., Shimazawa, M., Yoshimura, S., Iwama, T. and Hara, H. (2009): Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage. Neurosci. Lett., 452, 156-161.
23. Pereira, F.E., Coffin, J.D. and Beall, H.D. (2007): Activation of protein kinase C and disruption of endothelial monolayer integrity by sodium arsenite--Potential mechanism in the development of atherosclerosis. Toxicol. Appl. Pharmacol., 220, 164-177.
24. Revis, N.W., Zinsmeister, A.R. and Bull, R. (1981): Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion. Proc. Natl. Acad. Sci. USA, 78, 6494-6498.
25. Ross, R. (1993): The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362, 801-809.
26. Sato, M. and Bremner, I. (1993): Oxygen free radicals and metallothionein. Free Radic. Biol. Med., 14, 325-337.
27. Satoh, M. (2007): Analysis of toxicity using metallothionein knockout mice. Yakugaku Zasshi, 127, 709-717.
28. Shibuya, K., Nishimura, N., Suzuki, J.S., Tohyama, C., Naganuma, A. and Satoh M. (2008a): Role of metallothionein as a protective factor against radiation carcinogenesis. J. Toxicol. Sci., 33, 651-655.
29. Shibuya, K. Suzuki, J.S., Kito, H., Naganuma, A., Tohyama, C. and Satoh, M. (2008b): Protective role of metallothionein in bone marrow injury caused by X-irradiation. J. Toxicol. Sci., 33, 479-484.
30. Simeonova, P.P., Hulderman, T., Harki, D. and Luster, M.I. (2003): Arsenic exposure accelerates atherogenesis in apolipoprotein E-/-mice. Environ. Health Perspect., 111, 1744-1748.
31. Subramanyam, G., Bhaskar, M. and Govindappa, S. (1992): The role of cadmium induction of atherosclerosis in rabbits. Indian Heart J., 44, 177-180.
32. Suzuki, S., Masui, Y., Ohnuki, M., Miyakoda, G., Mori, T., Nakajima, K. and Sato, M. (2007): Induction of metallothionein synthesis by cilostazol in mice and in human cultured neuronal cell lines. Biol. Pharm. Bull., 30, 791-794.
33. Takaishi, M., Shimada, A., Suzuki, J.S., Satoh, M. and Nagase, H. (2010): Involvement of metallothionein (MT) as a biological protective factor against carcinogenesis induced by benzo[a] pyrene (B[a]P). J. Toxicol. Sci., 35, 225-230.
34. Takase, H., Hashimoto, A., Okutsu, R., Hirose, Y., Ito, H., Imaizumi, T., Miyakoda, G. and Mori, T. (2007): Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout mice. Arzeimittelforschung, 57, 185-191.
35. Wakida, K., Morimoto, N., Shimazawa, M., Hozumi, I., Nagase, H., Inuzuka, T. and Hara, H. (2006): Cilostazol reduces ischemic brain damage partly by inducing metallothionein-1 and-2. Brain Res., 1116, 187-193.
36. Wang, C.H., Jeng, J.S., Yip, P.K., Chen, C.L., Hsu, L.I., Hsueh, Y.M., Chiou, H.Y., Wu, M.M. and Chen, C.J. (2002): Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation, 105, 1804-1809.